Currently, there are 49.27M common shares owned by the public and among those 48.97M shares have been available to trade.
The company’s stock has a 5-day price change of -3.09% and -30.47% over the past three months. STAA shares are trading -8.23% year to date (YTD), with the 12-month market performance down to -24.39% lower. It has a 12-month low price of $21.13 and touched a high of $52.68 over the same period. STAA has an average intraday trading volume of 628.49K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.62%, -13.63%, and -37.64% respectively.
Institutional ownership of Staar Surgical Co (NASDAQ: STAA) shares accounts for 97.67% of the company’s 49.27M shares outstanding.
It has a market capitalization of $1.10B and a beta (3y monthly) value of 0.63. The stock’s trailing 12-month PE ratio is 50.88, while the earnings-per-share (ttm) stands at $0.44. The company has a PEG of 1.70 and a Quick Ratio of 5.38 with the debt-to-equity ratio at 0.09. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.60% over the week and 5.14% over the month.
Earnings per share for the fiscal year are expected to decrease by -31.81%, and 9.05% over the next financial year. EPS should shrink at an annualized rate of 30.00% over the next five years, compared to 31.51% over the past 5-year period.
Looking at the support for the STAA, a number of firms have released research notes about the stock. Morgan Stanley stated their Underweight rating for the stock in a research note on July 15, 2024, with the firm’s price target at $50-$37. BTIG Research coverage for the Staar Surgical Co (STAA) stock in a research note released on June 11, 2024 offered a Buy rating with a price target of $46. Morgan Stanley on their part issued Equal-Weight rating on December 04, 2023.
